Gastroenterologia Japonica

, Volume 23, Issue 4, pp 408–413 | Cite as

Interleukin 2 receptor bearing T lymphocytes in patients with chronic liver disease

  • Shinichi Kakumu
  • Kentaro Yoshioka
  • Akihiko Fuji
  • Hirofumi Tahara
Original Article


We investigated the role of interleukin 2 receptor expression (IL 2R) on T cell in chronic liver disease. IL 2R was determined by analysing T cell surface Tac antigen with anti-Tac, a monoclonal antibody that binds at or near the binding site for IL 2, using a fluorescence-activated cell sorter. The percentage of Tac+ cells in T cell fraction from peripheral blood mononuclear cells in unstimulated cultures was 7.9 ±2.1% (±SD) in controls. A similar value was obtained in asymptomatic carriers of HBsAg (ASC), in patients with chronic active hepatitis (CAH) and liver cirrhosis (LC). Upon stimulatin with recombinant IL 2, there was a small but significant increase in Tac+ cells. The percentages of Tac+ cells in IL 2-stimulated cultures were significantly lower in ASC (P<0.01), patients with CAH (P<0.01) and LC (P<0.05) as compared to controls (16.4 ±4.4%). Percentages of Tac+ cells after stimulation with phytohemagglutinin P (PHA-P) in ASC and CAH did not differ from controls (74.9 ±5.9%). Only patients with LC showed diminished Tac+ cells (P<0.01) compared to controls. During a 4-wk course of recombinant IL 2 therapy, a serial study on 5 HBeAg-positive patients with CAH was done, and the results showed that Tac+ cells were significantly diminished 2 wk (P<0.01) and 4 wk (P<0.05) after starting therapy in comparison with pretreatment levels in IL 2-stimulated cultures. OKT3+, OKT4+, OKT8+ cells in T cell culture in response to stimulation with PHA-P were significantly decreased in patients with CAH and LC when compared with controls. These results indicate that IL 2/ IL 2R system has a role on modulating immune resoponse in chronic liver disease.

Key words

Chronic liver disease Interleukin 2 receptor T lymphocyte 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Watson J, Mochizuki D: Interleukin 2: a class of T cell growth factors. Immunol Rev 1980;51:257–278PubMedCrossRefGoogle Scholar
  2. 2.
    Henry CS, Kuribayashi K, Kern DE, et al: Interleukin-2 augments natural killer cytotoxicity. Nature 1981;291:335–337CrossRefGoogle Scholar
  3. 3.
    Muraguchi A, Kehl JH, Butler JL, et al: Regulation of human B-cell activation, proliferation, and differentiation by soluble factors. J Clin Immunol 1984;4:337–347PubMedCrossRefGoogle Scholar
  4. 4.
    Nakagawa T, Hirano T, Nakagawa N, et al: Effect of recombinant IL 2 and γ-IFN on proliferation and differentiation of human B cells. J Immunol 1985;134:959–966PubMedGoogle Scholar
  5. 5.
    Robb RJ, Munck A, Smith KA: T cell growth factor receptors: quantitation, specificity, and biological relevance. J Exp Med 1981;154:1455–1474PubMedCrossRefGoogle Scholar
  6. 6.
    Uchiyama T, Broder S, Waldmann TA: A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. J Immunol 1981;126:1393–1397PubMedGoogle Scholar
  7. 7.
    Reem GH, Yeh NH: Interleukin 2 regualtes expression of its receptor and synthesis of gamma interferon by human T lymphocytes, Science 1984;225:429–430PubMedCrossRefGoogle Scholar
  8. 8.
    Leonard WJ, Depper JM, Uchiyama T, et al: A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor: partial characterization of the receptor. Nature 1982;300:267–269PubMedCrossRefGoogle Scholar
  9. 9.
    Robb RJ, Greene WC: Direct demonstration of the identity of T cell growth factor-binding protein and the Tac antigen. J Exp Med 1983; 158:1332–1337PubMedCrossRefGoogle Scholar
  10. 10.
    Abo T, Miller CA, Balch CM, et al: Interleukin 2 receptor expression by activated HNK-1 granular lymphocytes: a requirement for their proliferation. J Immunol 1983;131:1822–1826PubMedGoogle Scholar
  11. 11.
    Tsudo M, Uchiyama T, Uchino H: Expression of Tac antigen on activated normal human B cells. J Exp Med 1984;160:612–617PubMedCrossRefGoogle Scholar
  12. 12.
    Zubler RH, Lowenthal JW, Erard F, et al: Activated B cells express receptors for, and proliferate in response to, pure interleukin 2. J Exp Med 1984;160:1170–1183PubMedCrossRefGoogle Scholar
  13. 13.
    Yoshioka K, Kakumu S, Murakami H, et al: Interleukin-2 activity in chronic active liver diseases: response by T cells and in the autologous mixed lymphocyte reaction. Clin Exp Immunol 1984;56:668–676Google Scholar
  14. 14.
    Leevy CM, Popper H, Sherlock S: Disease of the liver and biliary tract: Standardization of nomenclature, diagnostic criteria and diagnostic methodology. Castle House Publications, London. 1979Google Scholar
  15. 15.
    Kakumu S, Hara T, Gohji H, et al: Inhibition of lymphocyte cytotoxicity in chronic active hepatitis. Clin Exp Immunol 1978;33:71–78PubMedGoogle Scholar
  16. 16.
    Kato K, Yamada T, Kawahara K, et al: Purification and characterization of recombinant human interleukin-2, Biochem biophys Res Commun 1985;130:692–699PubMedCrossRefGoogle Scholar
  17. 17.
    Rosenberg SA, Grimm EA, McGorgan M, et al: Biological activity of recombinant human interleukin-2 produced by Escherichia coli. Science 1984;223:1412–1414PubMedCrossRefGoogle Scholar
  18. 18.
    Naruo K, Himura S, Kato K, et al: Comparison of the biological properties of purified natural and recombinant human interluekin-2. Biochem biophys Res Commun 1985;128:257–264PubMedCrossRefGoogle Scholar
  19. 19.
    Weite K, Andreeff M, Platzer E, et al: Interleukin 2 regulates the expression of Tac antigen on peripheral blood T lymphoctes. J Exp Med 1984;160:1390–1403CrossRefGoogle Scholar
  20. 20.
    Depper JM, Leonard WJ, Drogula C, et al: Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene. Proc Natl Acad Sci USA 1985;82:4230–4234PubMedCrossRefGoogle Scholar
  21. 21.
    Sano H, Kumagai S, Naminuchi S, et al: Systemic lupus erythematosus sera antilymphocyte reactivity: detection of antibodies to Tac-antigen positive T cell lines. Clin Exp Immunol 1986;63:8–16PubMedGoogle Scholar
  22. 22.
    Alcocer-Varela J, Alarcon-Segovia D: Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J Clin Invest 1982;69:1388–1392PubMedCrossRefGoogle Scholar
  23. 23.
    Linker-Israeli M, Bakke AC, Kitridou RC, et al: Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J Immunol 1983;130:2651–2655PubMedGoogle Scholar
  24. 24.
    Kaye JS, Gillis S, Mizel SB, et al: Growth of cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2. J Immunol 1984;133:1339–1345PubMedGoogle Scholar

Copyright information

© The Japanese Society of Gastroneterology 1988

Authors and Affiliations

  • Shinichi Kakumu
    • 1
  • Kentaro Yoshioka
    • 1
  • Akihiko Fuji
    • 1
  • Hirofumi Tahara
    • 1
  1. 1.Third Department of MedicineNagoya University School of MedicineNagoyaJapan

Personalised recommendations